Rosuvastatin

InterventionStatins1 paper2 findingsPubChem 446157ChEBI 38545

Human trial1

Outcomes

2

Endoglin

downin humans1

1 study

Rosuvastatin decreases endoglin in humans.
“Atorvastatin and rosuvastatin therapies significantly decreased plasma concentrations of both endocan and endoglin”
Humansprimary cardiovascular preventionplasmaup to 16 weeksfemales
The Influence of Statin Therapy on Markers of Endothelial Dysfunction, Endocan and Endoglin, in Postmenopausal Women-A Prospective Study · Biomedicines · 27 Aug 2026

Endocan

downin humans1

1 study

Rosuvastatin decreases endocan in humans.
“Atorvastatin and rosuvastatin therapies significantly decreased plasma concentrations of both endocan and endoglin”
Humansprimary cardiovascular preventionplasmaup to 16 weeksfemales
The Influence of Statin Therapy on Markers of Endothelial Dysfunction, Endocan and Endoglin, in Postmenopausal Women-A Prospective Study · Biomedicines · 27 Aug 2026

Latest

1

BiomedicinesHuman trial26 Sep

The Influence of Statin Therapy on Markers of Endothelial Dysfunction, Endocan and Endoglin, in Postmenopausal Women-A Prospective Study